
Aceclofenac (100mg) + Paracetamol (325mg) + Thiocolchicoside (4mg)
Active composition
+2 more active ingredients
Aceclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which are responsible for pain and inflammation.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Esginac-MR Tablet is a combination analgesic and anti-inflammatory medication containing Thiocolchicoside (4mg), Aceclofenac (100mg), and Paracetamol (325mg). Thiocolchicoside is a muscle relaxant with anti-inflammatory properties, primarily used to relieve muscle spasms and associated pain. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), effectively reduces inflammation and pain by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis. Paracetamol serves as an analgesic and antipyretic, providing additional pain relief and fever reduction. The synergistic action of these three components makes Esginac-MR particularly useful in managing musculoskeletal conditions such as acute lower back pain, strains, sprains, and other soft tissue injuries where muscle spasm and inflammation coexist. It is indicated for short-term symptomatic treatment to improve patient mobility and comfort. Esginac-MR should be used under medical supervision, considering contraindications such as hypersensitivity to any component, peptic ulcer disease, severe hepatic or renal impairment, and caution in patients with cardiovascular risk factors. Common adverse effects may include gastrointestinal discomfort, dizziness, or allergic reactions. The combination should be taken as prescribed, and patients are advised to avoid concurrent use of other NSAIDs or hepatotoxic drugs to minimize potential risks.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Esginac-MR Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Esginac-MR Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of Esginac-MR Tablet in patients with kidney disease. Please consult your doctor.
Exercise Caution
It is not known whether Esginac-MR Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Esginac-MR Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Esginac-MR Tablet

Thiocolchicoside (4mg) + Aceclofenac (100mg) + Paracetamol (325mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Aceclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which are responsible for pain and inflammation.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Esginac-MR Tablet is a combination analgesic and anti-inflammatory medication containing Thiocolchicoside (4mg), Aceclofenac (100mg), and Paracetamol (325mg). Thiocolchicoside is a muscle relaxant with anti-inflammatory properties, primarily used to relieve muscle spasms and associated pain. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), effectively reduces inflammation and pain by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis. Paracetamol serves as an analgesic and antipyretic, providing additional pain relief and fever reduction. The synergistic action of these three components makes Esginac-MR particularly useful in managing musculoskeletal conditions such as acute lower back pain, strains, sprains, and other soft tissue injuries where muscle spasm and inflammation coexist. It is indicated for short-term symptomatic treatment to improve patient mobility and comfort. Esginac-MR should be used under medical supervision, considering contraindications such as hypersensitivity to any component, peptic ulcer disease, severe hepatic or renal impairment, and caution in patients with cardiovascular risk factors. Common adverse effects may include gastrointestinal discomfort, dizziness, or allergic reactions. The combination should be taken as prescribed, and patients are advised to avoid concurrent use of other NSAIDs or hepatotoxic drugs to minimize potential risks.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Esginac-MR Tablet during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Esginac-MR Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
There is limited information available on the use of Esginac-MR Tablet in patients with kidney disease. Please consult your doctor.
Exercise Caution
It is not known whether Esginac-MR Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
There is limited information available on the use of Esginac-MR Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
0 reviews for Esginac-MR Tablet











